Activated protein C formulations
US6395270B1 · kind B1 · utility
10Cited by
20References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2000 |
| Grant date | May 28, 2002 |
| Priority date | — |
| Expiry date | Sep 14, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21069
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical formulations of activated protein C which also comprises sucrose, sodium chloride and sodium citrate buffer at a pH between about 5.5 and about 6.5. The activated protein C formulations of the present invention are more stable than other formulations of activated protein C and demonstrate fewer degradation products over time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.